Immunome grants 86,500 inducement stock options at $27.07 per share
IMNM•Inducement stock options granted to new employees
- Immunome granted non-statutory stock options for 86,500 shares to four new employees under its 2024 Inducement Plan.
- Options carry an exercise price of $27.07 per share, set at the Sept. 1, 2026 closing price.
- Vesting runs four years: 25% after one year, then monthly over the next 36 months, subject to continued service.
